Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,139
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 12,001–12,020 of 17,237 recalls

FDA Recall Terminated Historical recordClass II

Salsalate Tablets, USP, 750 mg, packaged in a) 100 count bottles (NDC 42937-704-10); b) 500 count bottles (NDC 42937-704-18); and c) 1000 count bottles (NDC 42937-704-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.

by Nationwide Laboratories, LLC

Reason
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.

by Nationwide Laboratories, LLC

Reason
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: Burel Pharmaceuticals, Inc., Richland, MS --- NDC 35573-306-10

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Burel Pharmaceuticals, Inc., Richland, MS --- NDC 35573-304-10

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-314-10

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

UROPHEN MB URINARY ANTISEPTIC Tablets, Each tablet contains: Methenamine 81.6 mg, Benzoic Acid 9.0 mg, Phenyl Salicylate 36 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-307-10

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

URAMIT MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 118 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-300-10

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

UROLET MB URINARY ANTISEPTIC, ANTISPASMODIC Tablets, Each tablet contains: Methenamine 81.6 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue, 10.8 mg; Hyoscyamine Sulfate, 0.12 mg, (a) 30 count (NDC 35573-302-30) and (b) 100 count bottles (NDC 35573-302-10), Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine Sulfate 0.12 mg, Methenamine 81 mg, Methylene Blue 10.8 mg, Phenyl Salicylate 32.4 mg, Sodium Phosphate Monobasic 40.8 mg, 90 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-301-90

by Burel Pharmaceuticals Inc

Reason
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in India, Distributed by: Par Pharmaceutical Cos., Inc, Spring Valley, NY 10977

by Par Pharmaceutical, Inc.

Reason
Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

purely elizabeth.

Product
Chocolate Sea Salt Probiotic Granola, Purely Elizabeth, 8oz,…
Reason
Chocolate Sea Salt Probiotic Granola due to undeclared soy lecithin.
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Island Soups Company Inc.

Product
ISLAND SOUPS, FISH SOUP, NET WT. 16 OZ (28.4G)
Reason
Possible contamination with Clostridium botulinum
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Island Soups Company Inc.

Product
ISLAND SOUPS, RED PEAS SOUP, NET WT. 16 OZ (28.4G)
Reason
Possible contamination with Clostridium botulinum
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Island Soups Company Inc.

Product
ISLAND SOUPS, RED PEAS SOUP NO MEAT, NET WT. 16 OZ (28.4G)
Reason
Possible contamination with Clostridium botulinum
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Island Soups Company Inc.

Product
ISLAND SOUPS, GUNGO PEAS SOUP, NET WT. 16 OZ (28.4G)
Reason
Possible contamination with Clostridium botulinum
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Island Soups Company Inc.

Product
ISLAND SOUPS, GUNGO PEAS SOUP NO MEAT, NET WT. 16 OZ (28.4G)
Reason
Possible contamination with Clostridium botulinum
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Island Soups Company Inc.

Product
ISLAND SOUPS, MANNISH WATER, NET WT. 16 OZ (28.4G)
Reason
Possible contamination with Clostridium botulinum
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Rosa Foods HQ

Product
Soylent Food Bars, Net Wt. 2.12 oz (60g), 12 pack.
Reason
Rosa Foods is recalling Soylent Bar because a number of their customers have experienced gastrointestinal issues after consuming Soylent Bars.
Published
December 7, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Phenobarbital Tablets, USP 60mg 100=count bottles, Rx Only, Mfd. by: West-Ward Pharmaceutical Corp. Eatontown, NJ 07724, NDC 0143-1455-01

by West-Ward Pharmaceuticals Corp.

Reason
Failed Dissolution Specifications: Phenobarbital Tablets have an out of specification for dissolution at the 12 month stability time point
Published
November 30, 2016
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.